Endothelial sialyl Lewis X-modified integrin α3 drives fatty-acid metabolic reprogramming to shape Th17 plasticity in bladder cancer
Year: 2026
Type: article
Abstract: Tumor endothelial cells (TECs) are active regulators of the tumor immune microenvironment, and their surfaces are enriched with diverse glycans. However, the influence of endothelial glycosylation on immune regulation remains poorly understood. Here, we show that sialyl Lewis X (sLeX) glycosylation of integrin α3 (ITGA3) in endothelial cells (ECs) promotes endothelial-to-mesenchymal transition (Endo-MT) by stabilizing Slug and repressing CDH5 transcription via the EGFR-AKT-GSK3β axis. This process is accompanied by downregulation of fatty aldehyde dehydrogenase (FALDH/ALDH3A2), with impaired fatty acid oxidation and decreased mitochondrial ROS. Reduced ROS levels attenuated the production of the pro-inflammatory cytokines IL-1β and IL-6, enhanced TGF-β production, and reduced Th1-like Th17 responses, thereby favoring Treg-like Th17 phenotypes. Functionally, endothelial sLeX-modified ITGA3 reshapes the immune microenvironment toward a regulatory immune phenotype. Collectively, these findings identify a link between endothelial glycosylation, metabolic reprogramming, and immune regulation, and suggest that sLeX-modified ITGA3 contributes to endothelial-mediated modulation of Th17-associated responses in bladder cancer.
Source: Cell Death and Disease
Authors: Hui Feng, Huina Zhang, Feng Guan
Institution: Northwest University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: sialyl Lewis X, integrin alpha3, tumor endothelial cells, endothelial-to-mesenchymal transition, Slug, CDH5, fatty aldehyde dehydrogenase, fatty acid oxidation, mitochondrial reactive oxygen species, Th17 plasticity, regulatory T cells, tumor immune microenvironment, bladder cancer, IL-1β, interleukin-6, TGF-beta
Open Access status: gold
Estimated APC paid: $4,990
Awards: G1160203345, G1955597307, G725420190
OpenAlex ID: W7153060971
